文献速递多重用药老年慢病共病管理

药师主导的阿司匹林去处方算法在老年患者中的开发与实施

Development and Implementation of a Pharmacist-Led Aspirin Deprescribing Algorithm in Older Adults.
PubMed 文献 · J Am Geriatr Soc · 2025-04-15

该研究在两家基层诊所开发并实施药师主导的阿司匹林去处方算法,纳入70岁以上低剂量阿司匹林使用者。实施后不适当阿司匹林使用率从24.9%降至20.3%(p<0.01),亚组分析未观察到出血及心血管事件差异。

要点

  • 药师主导的去处方算法可降低老年不适当阿司匹林使用率。
  • 实施后不适当使用率为20.3%,较实施前24.9%显著下降(p<0.01)。
  • 亚组分析未观察到出血及心血管事件差异。

核心结论

  • 去处方算法与老年不适当阿司匹林使用率显著降低相关。
  • 基于算法的去处方可降低老年出血风险和多药共用。

研究设计与样本

  • 研究为经机构审查委员会批准的前后干预研究,在两家基层诊所开展。
  • 由跨学科团队开发阿司匹林去处方算法,药师通过病历审查筛选适合去处方的患者。
  • 实施前阶段适合去处方的患者作为实施后阶段的干预组,总随访5个月。

主要发现

  • 实施前组不适当阿司匹林使用率为24.9%,118例患者适合去处方。
  • 实施后组22例患者阿司匹林被去处方,不适当使用率为20.3%(p<0.01)。
  • 亚组分析未观察到大出血、小出血、主要心血管事件及心血管相关住院的差异。

关键数值与推荐

  • 不适当阿司匹林使用定义为患者电子健康记录中无动脉粥样硬化性心血管疾病(ASCVD)诊断而使用阿司匹林。
  • 出血事件依据国际血栓与止血学会标准判定。

临床怎么用

  • 在老年患者中可应用药师主导的去处方算法识别并停用无ASCVD诊断的低剂量阿司匹林。
  • 去处方决策需结合病历审查确认ASCVD诊断状态。
  • 实施过程中应监测出血及心血管事件等安全终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent literature has demonstrated that low-dose aspirin for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in older adults has been associated with a higher incidence of bleeding events without additional benefit compared to standard prevention strategies. This study evaluated the impact of an aspirin deprescribing algorithm on inappropriate aspirin use in patients older than 70 years across two primary care offices. METHODS: This institutional review board-approved, pre- and post-interventional study included patients 70 years and older on low-dose aspirin with office visits scheduled from April 1, 2023-March 30, 2024. An aspirin deprescribing algorithm was developed by an interdisciplinary team to guide prescribers with deprescribing. The pharmacist screened patients eligible for deprescribing via chart review of visits from April 2023-October 2023. Patients eligible for deprescribing in the pre-implementation phase were included as the interventional group of the post-implementation phase (November 2023-March 2024). Follow-up was 5 months total. The primary endpoint was incidence of inappropriate aspirin use, defined as patients taking aspirin without documented diagnosis of ASCVD in patients' electronic health record. A subgroup analysis was performed on patients who were eligible for deprescribing and monitored safety endpoints such as incidence of major and minor bleeds based on the International Society on Thrombosis and Hemostasis criteria, major cardiovascular events, and cardiovascular-related hospitalizations. Duration of follow-up for secondary endpoints was 5 months during the post-implementation period. RESULTS: Four-seventy four patients were included. The incidence of inappropriate aspirin use in the pre-implementation group was 24.9% and 118 patients were eligible for deprescribing. For the post-implementation group, 22 patients had aspirin deprescribed, resulting in 20.3% inappropriate aspirin use (p < 0.01). In the subgroup analysis, no difference of major and minor bleeds, major cardiovascular events, and cardiovascular-related hospitalizations were observed. CONCLUSION: A deprescribing algorithm was associated with a statistically significant reduction in inappropriate aspirin use in older adults for the indication of primary ASCVD prevention. Algorithm-based deprescribing can reduce bleeding risk and polypharmacy in older adults.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Sano U, Uricchio M, Redling T, et al. Development and Implementation of a Pharmacist-Led Aspirin Deprescribing Algorithm in Older Adults. J Am Geriatr Soc. 2025. PMID: 40231564. doi:10.1111/jgs.19474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。